Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05396105
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:12.793404+00:00
Published At
2026-03-16T00:00:00+00:00
Record Updated At
2026-03-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hereditary Angioedema", "Hereditary Angioedema Type I", "Hereditary Angioedema Type II", "Hereditary Angioedema Types I and II", "Hereditary Angioedema Attack", "Hereditary Angioedema With C1 Esterase Inhibitor Deficiency", "Hereditary Angioedema - Type 1", "Hereditary Angioedema - Type 2", "Hereditary Angioedema - Type 3", "C1 Esterase Inhibitor [C1-INH] Deficiency", "C1 Esterase Inhibitor Deficiency", "C1 Esterase Inhibitor, Deficiency of", "C1 Inhibitor Deficiency", "Hereditary Angioedema Type III", "Hereditary Angioedema (HAE)", "Hereditary Angioedema Type I and II"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-16"
protocolSection.identificationModule.nctId
"NCT05396105"
protocolSection.identificationModule.officialTitle
"A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hereditary Angioedema (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema Type I (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema Type II (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema Types I and II (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema Attack (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema With C1 Esterase Inhibitor Deficiency (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema - Type 1 (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema - Type 2 (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema - Type 3 (protocolSection.conditionsModule.conditions)
  • C1 Esterase Inhibitor [C1-INH] Deficiency (protocolSection.conditionsModule.conditions)
  • C1 Esterase Inhibitor Deficiency (protocolSection.conditionsModule.conditions)
  • C1 Esterase Inhibitor, Deficiency of (protocolSection.conditionsModule.conditions)
  • C1 Inhibitor Deficiency (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema Type III (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema (HAE) (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema Type I and II (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.